Bio Developments

Manufacturing deals for DSM, Lonza, ARk and AMRI

News from Lonza, DSM, Ark and AMRI presents a roundup of contract manufacturing news with deals for Lonza, DSM and Ark Therapeutics and an expanded agreement with Shire for AMRI.  

Genetically modified corn could soon make drugs

GM corn could soon be used to make drugs

By Natalie Morrison

Genetically modified corn could soon be used to mass-produce the enzymes used in rare-disease therapies, according to new research.

GE rolls out 'off the shelf' MAb factories

GE launches range of 'off the shelf' MAb facilities

By Gareth Macdonald

GE Healthcare has launched an ‘off-the-shelf’ range of modular biomanufacturing facilities that it claims can be designed, constructed and operational in under two years.

Follow us